MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Legionella Detected at Michigan Health Facility
Case follows a similar finding of Legionnaires’ disease in a former patient.
Crystal Spring Tower Opens at Carilion Roanoke Memorial Hospital
The new cardiovascular institute improves access and care across the region.
Hospital Evacuation Highlights Importance of Emergency Preparedness
Berger Hospital was evacuated after smoke was discovered in the basement.
Building a Culture of Infection Prevention
Investing in infection prevention can benefit healthcare organizations and patient outcomes.
Ground Broken on Sanford Health Fargo's Peltier Lodge
The 28,400-square-foot facility will feature spaces to support patients and loved ones during treatment and throughout their outpatient care and monitoring.